Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial cell membrane and its associated surface proteins serve as the fundamental boundary between a microorganism and its environment (Nature Reviews Microbiology, 2015). This complex structure is composed of a lipid bilayer interspersed with proteins that facilitate essential processes such as nutrient uptake, waste excretion, and environmental sensing. In bacteria, the membrane is often protected by a cell wall, while in fungi, it contains unique sterols like ergosterol that maintain fluidity (Journal of Fungi, 2020). These structures are vital therapeutic targets; for instance, lipopeptides like daptomycin insert into the bacterial membrane to cause depolarization and cell death (StatPearls: Daptomycin, 2023). Similarly, polyene antifungals like amphotericin B bind to ergosterol to create lethal pores in fungal membranes (StatPearls: Amphotericin B, 2023). Surface proteins, such as penicillin-binding proteins (PBPs), are also critical targets for beta-lactam antibiotics which inhibit cell wall synthesis. Despite their utility, targeting these structures can be challenging due to potential cross-reactivity with host cell membranes, leading to side effects like nephrotoxicity (StatPearls: Polymyxin B, 2023). Understanding the specific composition of these membranes is crucial for developing narrow-spectrum agents that minimize damage to the host microbiome.
Drugs targeting this complex typically act by disrupting the physical integrity of the lipid bilayer, forming transmembrane pores, or inhibiting the enzymatic activity of surface proteins involved in cell wall assembly (StatPearls: Polymyxin B, 2023; StatPearls: Daptomycin, 2023).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and associated surface proteins.